Fig. 7From: Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patientsDNAH mutations detected by targeted sequencing in 64 gastric cancer patients who underwent chemotherapy. a For each gene (row) indicated, tumors (columns) with mutations are labeled with red (missense mutations), blue (silent mutations), or brown (frameshift indels) bars. The lower labels with green (sensitive) bars and pink (resistant) bars represent the chemotherapy response status of each individual patient. b Sex, Lauren classification and age are shown for each patient. The P value shows the result of the comparison between the patients with DNAH mutations vs patients with wild-type DNAH genesBack to article page